Sign in

CIK 0001378325 · <br>Emerging growth company

CapsoVision, Inc

Sign in to watch
Ticker
CV
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203369494
Phone
(408) 370-4790
Business address
18805 COX AVENUE SUITE 250, SARATOGA, CA, 95070
Former names
Capso Vision Inc
Open-market buys, last 90 days
$19,999,992
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$19,999,992. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. HARARI ELIYAHOU ET AL +$10.0M 10% owner 1 filing
  2. Shen Ching Hang +$10.0M 10% owner 2 filings
Date Insider Transaction Shares Price Value Owned after
2025-07-03 HARARI ELIYAHOU ET AL 10% owner Conversion · Series D-2 Preferred Stock −934,588 0
2025-07-03 HARARI ELIYAHOU ET AL 10% owner Conversion · Series E Preferred Stock −434,782 0
2025-07-03 HARARI ELIYAHOU ET AL 10% owner Conversion · Series F-1 Preferred Stock −434,783 0
2025-07-03 HARARI ELIYAHOU ET AL 10% owner Conversion · Series F-2 Preferred Stock −2,000,000 0
2025-07-03 HARARI ELIYAHOU ET AL 10% owner Conversion · Series G Preferred Stock −740,741 0
2025-07-03 HARARI ELIYAHOU ET AL 10% owner Conversion · Series G-1 Preferred Stock −1,206,898 0
2025-07-03 HARARI ELIYAHOU ET AL 10% owner Conversion · Series H Preferred Stock −4,638,377 0
2025-07-03 HARARI ELIYAHOU ET AL 10% owner Conversion · Series H Preferred Stock −1,724,139 0
2025-07-03 HARARI ELIYAHOU ET AL 10% owner Conversion · Series H Preferred Stock −1,724,139 0
2025-07-03 King Wen-Herng Henry Director Conversion +20,710 20,710
2025-07-03 King Wen-Herng Henry Director Conversion · Series H Preferred Stock −68,966 0
2025-07-03 Kuo Hui Ying Director Conversion +10,354 10,354
2025-07-03 Kuo Hui Ying Director Conversion · Series H Preferred Stock −34,482 0
2025-07-03 Tsai Chen Lung Director Conversion +91,432 115,456
2025-07-03 Tsai Chen Lung Director Conversion · Series B Preferred Stock −71,429 0
2025-07-03 Tsai Chen Lung Director Conversion · Series D-1 Preferred Stock −55,555 0
2025-07-03 Tsai Chen Lung Director Conversion · Series E Preferred Stock −86,956 0
2025-07-03 Tsai Chen Lung Director Conversion · Series H Preferred Stock −90,534 0
2025-07-03 Wang Kang-Huai See Remarks Conversion +446,896 721,732
2025-07-03 Wang Kang-Huai See Remarks Conversion · Series A Preferred Stock −1,407,407 0

Page 5 of 6 · 103 trades